Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.…
Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
Abrdn Healthcare Investors (NYSE: HQH) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Asset Management industry, part of the Financial Services sector.
The shares were at 18.85 USD on 20 November 2026, up 9.6% over 52 weeks. Its 52-week range is 17.14 USD to 24.85 USD: the price is 24.1% below the high and 10.0% above the low.
At a market capitalisation of 1.08B USD, it trades at 4.2 times trailing earnings. The median trailing P/E of its 18 largest Asset Management peers is 14.8, a discount of 72% for HQH. It pays a dividend yielding 13.32% (it pays out 50% of its earnings), against a median of 1.81% among the dividend payers in that peer group.
Abrdn Healthcare Investors reports return on equity of 9.0%, an operating margin of -106.6% and revenue down 42.1% year over year.
Its Piotroski F-score is 1 out of 9, a weak reading of its financial health.
No upcoming events tracked.